Novel nitrogen-based chalcone analogs provoke substantial apoptosis in HER2-positive human breast cancer cells via JNK and ERK1/ERK2 signaling pathways
Author | Rizeq, Balsam |
Author | Gupta, Ishita |
Author | Kheraldine, Hadeel |
Author | Elkhalifa, Dana |
Author | Al-Farsi, Halema F. |
Author | Moustafa, Ala-Eddin A. |
Author | Khalil, Ashraf |
Available date | 2023-01-23T05:30:13Z |
Publication Date | 2021 |
Publication Name | International Journal of Molecular Sciences |
Resource | Scopus |
Abstract | Natural chalcones possess antitumor properties and play a role as inducers of apoptosis, antioxidants and cytotoxic compounds. We recently reported that novel nitrogen chalcone-based compounds, which were generated in our lab, have specific effects on triple-negative breast cancer cells. However, the outcome of these two new compounds on human epidermal growth factor receptor 2 (HER2)-positive breast cancer remains nascent. Thus, we herein investigated the effects of these compounds (DK-13 and DK-14) on two HER2-positive breast cancer cell lines, SKBR3 and ZR75. Our data revealed that these compounds inhibit cell proliferation, deregulate cell-cycle progression and significantly induce cell apoptosis in both cell lines. Furthermore, the two chalcone compounds cause a significant reduction in the cell invasion ability of SKBR3 and ZR75 cancer cells. In parallel, we found that DK-13 and DK-14 inhibit colony formation of both cell lines in comparison to their matched controls. On the other hand, we noticed that these two compounds can inhibit angiogenesis in the chorioallantoic membrane model. The molecular pathway analysis of chalcone compounds exposed cells revealed that these compounds inhibit the expression of both JNK1/2/3 and ERK1/2, the major plausible molecular pathways behind these events. Our findings implicate that DK-13 and DK-14 possess effective chemotherapeutic outcomes against HER2-positive breast cancer via the ERK1/2 and JNK1/2/3 signaling pathways. |
Sponsor | Funding: This research was funded by the following Qatar University Grants: (QUCG-CPH-20/21-4), (QUCP-CMED-2019-1) and (QUHI-CMED-19/20-1). |
Language | en |
Publisher | MDPI |
Subject | Apoptosis Breast cancer Chalcones Chemoprevention HER2-positive |
Type | Article |
Issue Number | 17 |
Volume Number | 22 |
Files in this item
This item appears in the following Collection(s)
-
Biomedical Research Center Research [738 items ]
-
Medicine Research [1509 items ]
-
Pharmacy Research [1314 items ]